Guaiphenesin PCD Pharma Franchise Company
Cafoli Lifecare offers 2 Guaiphenesin cough syrup formulations for PCD pharma franchise and third-party manufacturing. Every batch is produced in WHO-GMP certified facilities, giving distributors a fast-moving expectorant for the cough-and-cold segment.
What is Guaiphenesin?
Guaiphenesin (guaifenesin) is an expectorant. It increases the volume and reduces the viscosity of respiratory tract secretions, helping to loosen phlegm and make coughs more productive so mucus is cleared more easily. See MedlinePlus for detailed drug information.
Therapeutic Applications
Guaiphenesin is used to relieve chest congestion and productive cough associated with colds, bronchitis and other respiratory infections, often combined with cough suppressants, antihistamines or bronchodilators. It is prescribed by general physicians, paediatricians, chest physicians and ENT specialists.
Why Guaiphenesin is a High-Potential Molecule for Distributors
Cough-and-cold is one of India’s largest and most consistent therapy segments, with demand year-round and peaking every winter and monsoon. Expectorant syrups move quickly on both prescription and OTC counters, so guaiphenesin offers franchise partners high turnover and dependable repeat volume rather than seasonal spikes alone.
Why Choose Cafoli Lifecare
Cafoli Lifecare supports partners with monopoly PCD rights, WHO-GMP manufacturing, DCGI-approved formulations, complete promotional inputs and a network of 1000+ franchise partners across India.
References
- MedlinePlus – Guaifenesin
- PubChem – Guaifenesin
- PubMed – Guaifenesin research
Our formulations of Guaiphenesin find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to: